Macrophage-directed tumour immunotherapy revisited — past and future of an old doctor's dilemma
- 31 December 1993
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 144 (4) , 291-298
- https://doi.org/10.1016/0923-2494(93)80111-b
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Macrophage heterogeneity and differentiation: defined serum-free culture conditions induce different types of macrophages in vitroResearch in Immunology, 1992
- Human macrophages secrete a tumoricidal activity distinct from tumour necrosis factor-α and reactive nitrogen intermediatesResearch in Immunology, 1992
- Characterization and partial purification of a high molecular weight tumoricidal activity secreted by murine bone marrow macrophagesInternational Immunology, 1992
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Adoptive Immunotherapy with Autologous Macrophages: Current Status and Future PerspectivesPathobiology, 1991
- Tumor-associated macrophagesCurrent Opinion in Immunology, 1990
- IL‐1 and IL‐6 release by tumor‐associated macrophages from human ovarian carcinomaInternational Journal of Cancer, 1989
- Macrophages associated with murine tumours express plasminogen activator activityInternational Journal of Cancer, 1988
- IS CANCER A MACROPHAGE-MEDIATED AUTOAGGRESSIVE DISEASE?The Lancet, 1987
- Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumorsInternational Journal of Cancer, 1984